Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006
Código 3822 (Harmonized System 2012 by 4 digits)
In 2023, the main commercial destinations of Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006 were United States (US$249M), Canada (US$3.55M), Costa Rica (US$621k), Cuba (US$394k), and Guatemala (US$228k).
The main commercial origins of Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006 in 2023 were United States (US$317M), China (US$144M), Germany (US$130M), United Kingdom (US$45.4M), and Spain (US$23.2M).
In the global context, the main exporting countries of Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006 in 2022 were N/A. In the same year, the main importing countries of Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006 were United States (US$9.17B), Germany (US$6.21B), and China (US$3.87B).
Trade Balance of Mexico
#permalink to sectionNet Trade Balance
#permalink to sectionThe visualizations show the net balance of Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006 at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
Net International Trade
#permalink to sectionFebruary, 2023
- US$61.9M, International Purchases
- US$21.6M, International Sales
In February 2023, international sales of Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006 were US$21.6M, while international purchases reached US$61.9M. The above results in a trade balance of -US$40.3M.
Market Concentration
#permalink to section2023-Q1: US$54.7M, International Sales
The visualization shows the quarterly concentration of international sales of Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006 at state level.
In the first quarter of 2023, international sales were US$54.7M, being the states with the most sales Baja California (US$33.7M), Chihuahua (US$20.4M), and Ciudad de México (US$330k).
Exchange by Territory
#permalink to sectionInternational Sales
#permalink to sectionUnited States: US$249M, Main commercial destination (2023)
In 2023, the countries with the most international purchases from Mexico were United States (US$249M), Canada (US$3.55M), Costa Rica (US$621k), Cuba (US$394k), and Guatemala (US$228k).
International Purchases
#permalink to sectionUnited States: US$317M, Main Commercial Origin (2023)
The countries with the most international sales to Mexico in 2023 were United States (US$317M), China (US$144M), Germany (US$130M), United Kingdom (US$45.4M), and Spain (US$23.2M).
Specialization
#permalink to sectionSpecialization by State
#permalink to sectionThe RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006 and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
Global Market
#permalink to sectionOrigins and Trade Destinations
#permalink to section- 0.37%, Mexican share in global exports - 2022
- 0.8%, Mexican share in global imports - 2022
The visualizations show the global market for Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006 were N/A. In the same year, the main importing countries for Diagnostic or Laboratory Reagents on a Backing and Prepared Diagnostic, other than those of Heading No. 3002 or 3006 were United States (US$9.17B), Germany (US$6.21B), and China (US$3.87B).